Results 211 to 220 of about 14,630 (228)

NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study

Lancet Neurology, The, 2008
Jeffrey K Tobias
exaly  

EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trial

Lancet, The, 2014
Andrew S C Rice, Gary R Cutter
exaly  

Safety and efficacy of a Nav1.7 selective sodium channel blocker in patients with trigeminal neuralgia: a double-blind, placebo-controlled, randomised withdrawal phase 2a trial

Lancet Neurology, The, 2017
Joanna M Zakrzewska, Mark Obermann, Dominik A Ettlin   +2 more
exaly  

Significance of neurovascular contact in classical trigeminal neuralgia

Brain, 2015
Stine Maarbjerg, Jes Olesen, Lars Bendtsen   +2 more
exaly  

Trigeminal Neuralgia

New England Journal of Medicine, 2020
Giorgio Cruccu, Giulia Di Stefano, Andrea Truini   +2 more
exaly  

A systematic review and meta-analysis of risk factors for postherpetic neuralgia

Pain, 2016
Harriet J Forbes, Liam Smeeth
exaly  

A Comprehensive Review of Trigeminal Neuralgia

Current Pain and Headache Reports, 2019
Mark R Jones, Ivan Urits, Daniel J Park
exaly  

Trigeminal Neuralgia – A Prospective Systematic Study of Clinical Characteristics in 158 Patients

Headache, 2014
Stine Maarbjerg, Jes Olesen, Lars Bendtsen   +2 more
exaly  

Current and Innovative Pharmacological Options to Treat Typical and Atypical Trigeminal Neuralgia

Drugs, 2018
Andrea Truini, Giorgio Cruccu
exaly  

Evaluating the impact of trigeminal neuralgia

Pain, 2017
Joanna M Zakrzewska, Jianhua Wu, Susan Pavitt   +2 more
exaly